NYSE:DVA - Davita Stock Price, Forecast & News

Davita's stock was trading at $74.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DVA stock has decreased by 2.4% and is now trading at $73.09. View which stocks have been mosted impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Davita.

Davita is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Davita.

Davita Inc (NYSE:DVA) announced its earnings results on Monday, February, 10th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.66 by $0.20. The business earned $2.90 billion during the quarter, compared to analysts' expectations of $2.92 billion. Davita had a net margin of 7.12% and a return on equity of 25.18%. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.90 earnings per share. View Davita's earnings history.

Davita updated its FY20 earnings guidance on Monday, February, 10th. The company provided earnings per share (EPS) guidance of $5.75-6.25 for the period, compared to the Thomson Reuters consensus estimate of $5.58. The company issued revenue guidance of $11.50-11.70 billion, compared to the consensus revenue estimate of $11.57 billion.

10 equities research analysts have issued 1 year price objectives for Davita's shares. Their forecasts range from $57.00 to $90.00. On average, they expect Davita's stock price to reach $67.83 in the next twelve months. This suggests that the stock has a possible downside of 7.2%. View analysts' price targets for Davita.

Headlines about DVA stock have been trending negative recently, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Davita earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutDavita.

Davita saw a increase in short interest in March. As of March 13th, there was short interest totaling 6,585,500 shares, an increase of 8.9% from the February 27th total of 6,050,000 shares. Based on an average daily volume of 1,360,000 shares, the short-interest ratio is presently 4.8 days. Approximately 5.4% of the company's stock are sold short. View Davita's Current Options Chain.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), R1 RCM (RCM), MEDNAX (MD), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), United Rentals (URI), AutoZone (AZO), Walt Disney (DIS) and Designer Brands (DBI).

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita's stock is owned by a number of institutional and retail investors. Top institutional investors include State Street Corp (3.72%), Norges Bank (2.79%), Bank of New York Mellon Corp (1.71%), Geode Capital Management LLC (1.33%), Thornburg Investment Management Inc. (0.77%) and Boston Partners (0.67%). Company insiders that own Davita stock include Charles Berg, John M Nehra, Pamela M Arway and William L Roper. View institutional ownership trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., FMR LLC, State Street Corp, Thornburg Investment Management Inc., Bank of Montreal Can, DekaBank Deutsche Girozentrale, Jarislowsky Fraser Ltd, and UBS Group AG. Company insiders that have sold Davita company stock in the last year include John M Nehra, and Pamela M Arway. View insider buying and selling activity for Davita.

DVA stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Bank of New York Mellon Corp, AQR Capital Management LLC, Covenant Multifamily Offices LLC, Schroder Investment Management Group, Great West Life Assurance Co. Can, Prudential Financial Inc., and Mackay Shields LLC. View insider buying and selling activity for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $73.09.

Davita has a market capitalization of $9.18 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe. View additional information about Davita.

The official website for Davita is http://www.davita.com/.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]